MaRS Innovation and others commit over $1 Million to rapid molecular diagnostic technology

0 October 27, 2010

MaRS Innovation announced a $500,000 investment in the Toronto company, Xagenic Inc. When combined with funds from other investors and lenders, the new working capital provided to Xagenic totals $1.04 million. 

Leave a Reply

Your email address will not be published. Required fields are marked *